Medicare Enrolled

Dr. Christopher Schwarz, MD

Gastroenterology · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2601 LAKE DR, Raleigh, NC 27607
9197834888
In practice since 2007 (19 years)
NPI: 1649319195 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwarz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwarz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwarz

Dr. Christopher Schwarz is a gastroenterology specialist in Raleigh, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schwarz performed 495 Medicare services across 482 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwarz received a total of $10,647 from 47 pharmaceutical and/or device companies across 636 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwarz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in NC $10,647 industry payments

Medicare Practice Summary

Medicare Utilization ↗
495
Medicare services
Top 50% in NC for gastroenterology
482
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
136 $186 $1,650
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
84 $52 $1,132
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $89 $213
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
32 $105 $1,194
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
32 $124 $1,413
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
27 $172 $1,225
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
22 $137 $1,315
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
20 $67 $966
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $108 $328
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
19 $172 $1,194
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
15 $96 $355
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
15 $74 $213
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
41.2% medium
55.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,647
Total received (2018-2024)
Avg $1,521/year across 7 years
Top 16% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
636
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,557 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,682
2023
$2,182
2022
$1,849
2021
$785
2020
$345
2019
$1,337
2018
$1,467

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$664
PFIZER INC.
$202
Phathom Pharmaceuticals, Inc.
$184
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$178
Janssen Biotech, Inc.
$156
Regeneron Healthcare Solutions, Inc.
$146
Lilly USA, LLC
$144
Ipsen Biopharmaceuticals, Inc
$121
Takeda Pharmaceuticals U.S.A., Inc.
$116
Madrigal Pharmaceuticals
$97
Celltrion USA Inc.
$90
Ardelyx, Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Merck Sharp & Dohme LLC
$51
GENZYME CORPORATION
$46
Celgene Corporation
$42
Organon Llc
$38
Ferring Pharmaceuticals Inc.
$37
EVOKE PHARMA, INC.
$36
Intercept Pharmaceuticals, Inc.
$34
Alnylam Pharmaceuticals Inc.
$30
AIMMUNE THERAPEUTICS, INC.
$25
Aurinia Pharma U.S., Inc.
$22
QOL Medical, LLC
$21
Gilead Sciences, Inc.
$20
VIVUS LLC
$19
IRONWOOD PHARMACEUTICALS, INC
$18
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,432
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,108
AbbVie Inc.
$1,035
PFIZER INC.
$972
AbbVie, Inc.
$735
Takeda Pharmaceuticals U.S.A., Inc.
$678
Janssen Biotech, Inc.
$543
Regeneron Healthcare Solutions, Inc.
$384
Gilead Sciences, Inc.
$347
Celgene Corporation
$344
Intercept Pharmaceuticals, Inc.
$213
Ferring Pharmaceuticals Inc.
$189
Phathom Pharmaceuticals, Inc.
$184
Lilly USA, LLC
$162
QOL Medical, LLC
$147
Merck Sharp & Dohme LLC
$137
Braintree Laboratories, Inc.
$133
GENZYME CORPORATION
$124
Allergan Inc.
$122
Ipsen Biopharmaceuticals, Inc
$121
Ardelyx, Inc.
$120
E.R. Squibb & Sons, L.L.C.
$118
Synergy Pharmaceuticals Inc
$106
INTERCEPT PHARMACEUTICALS, INC.
$106
Madrigal Pharmaceuticals
$97
Celltrion USA Inc.
$90
UCB, Inc.
$83
Daiichi Sankyo Inc.
$82
Janssen Pharmaceuticals, Inc
$74
Nestle HealthCare Nutrition Inc.
$68
Merck Sharp & Dohme Corporation
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Ironwood Pharmaceuticals, Inc
$61
RedHill Biopharma Inc.
$54
Shionogi Inc
$50
Evoke Pharma, Inc.
$45
Organon Llc
$38
EVOKE PHARMA, INC.
$36
Alnylam Pharmaceuticals Inc.
$30
AIMMUNE THERAPEUTICS, INC.
$25
Aurinia Pharma U.S., Inc.
$22
Organon LLC
$22
VIVUS LLC
$19
IRONWOOD PHARMACEUTICALS, INC
$18
Sandoz Inc.
$17
Endo Pharmaceuticals Inc.
$15
Amgen Inc.
$13
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
APRISO · Amitiza · CIMZIA · CLENPIQ · CREON · CYCLOSET · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · Enbrel · Entyvio · GATTEX · GIMOTI · GIVLAARI · HADLIMA · HUMIRA · HYRIMOZ · Humira · IBSRELA · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · LUPKYNIS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Mulpleta · NASCOBAL · OCALIVA · OFEV · OMVOH · QSYMIA · REBYOTA · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Raleigh?
Compare gastroenterologists in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
109
Per 100K population
9.5
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schwarz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schwarz experienced with colon polyp removal with endoscopic snare?
Based on Medicare claims data, Dr. Schwarz performed 136 colon polyp removal with endoscopic snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwarz receive payments from pharmaceutical companies?
Yes. Dr. Schwarz received a total of $10,647 from 47 companies across 636 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwarz's costs compare to other gastroenterologists in Raleigh?
Dr. Schwarz's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwarz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →